Identification of cancer genes by mutational profiling of tumor genomes

Silvia Benvenuti, Sabrina Arena, Alberto Bardelli

Research output: Contribution to journalArticle

Abstract

It is now widely accepted that cancer is a genetic disease and that alterations in the DNA sequence underlie the development of every neoplasm. The identification of mutated genes that are causally implicated in oncogenesis ('cancer genes') has been a major goal in medical sciences for the last two decades. The availability of the human genome sequence coupled to the introduction of high throughput sequencing technologies has created an unprecedented opportunity in this field. It is now possible to perform mutational studies of entire cancer genomes thus providing a complete description of mutations underlying human oncogenesis. The recent identification of high frequency mutations in the BRAF and PI3K genes suggests that many more cancer genes remain to be discovered. In this review, we consider how the systematic mutational analysis of gene families in individual neoplasms has led to the identification of a number of cancer genes and how this information is influencing the treatment of cancer.

Original languageEnglish
Pages (from-to)1884-1890
Number of pages7
JournalFEBS Letters
Volume579
Issue number8
DOIs
Publication statusPublished - Mar 21 2005

Fingerprint

Neoplasm Genes
Tumors
Genes
Genome
Neoplasms
Carcinogenesis
Inborn Genetic Diseases
Human Genome
Mutation Rate
Phosphatidylinositol 3-Kinases
DNA sequences
Technology
Mutation
Throughput
Availability

Keywords

  • Cancer genome
  • Gene family
  • Mutational analysis
  • Oncogenomics
  • Tailored therapies

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Identification of cancer genes by mutational profiling of tumor genomes. / Benvenuti, Silvia; Arena, Sabrina; Bardelli, Alberto.

In: FEBS Letters, Vol. 579, No. 8, 21.03.2005, p. 1884-1890.

Research output: Contribution to journalArticle

@article{4cc836a722064d99988aa37251832b4e,
title = "Identification of cancer genes by mutational profiling of tumor genomes",
abstract = "It is now widely accepted that cancer is a genetic disease and that alterations in the DNA sequence underlie the development of every neoplasm. The identification of mutated genes that are causally implicated in oncogenesis ('cancer genes') has been a major goal in medical sciences for the last two decades. The availability of the human genome sequence coupled to the introduction of high throughput sequencing technologies has created an unprecedented opportunity in this field. It is now possible to perform mutational studies of entire cancer genomes thus providing a complete description of mutations underlying human oncogenesis. The recent identification of high frequency mutations in the BRAF and PI3K genes suggests that many more cancer genes remain to be discovered. In this review, we consider how the systematic mutational analysis of gene families in individual neoplasms has led to the identification of a number of cancer genes and how this information is influencing the treatment of cancer.",
keywords = "Cancer genome, Gene family, Mutational analysis, Oncogenomics, Tailored therapies",
author = "Silvia Benvenuti and Sabrina Arena and Alberto Bardelli",
year = "2005",
month = "3",
day = "21",
doi = "10.1016/j.febslet.2005.02.015",
language = "English",
volume = "579",
pages = "1884--1890",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Identification of cancer genes by mutational profiling of tumor genomes

AU - Benvenuti, Silvia

AU - Arena, Sabrina

AU - Bardelli, Alberto

PY - 2005/3/21

Y1 - 2005/3/21

N2 - It is now widely accepted that cancer is a genetic disease and that alterations in the DNA sequence underlie the development of every neoplasm. The identification of mutated genes that are causally implicated in oncogenesis ('cancer genes') has been a major goal in medical sciences for the last two decades. The availability of the human genome sequence coupled to the introduction of high throughput sequencing technologies has created an unprecedented opportunity in this field. It is now possible to perform mutational studies of entire cancer genomes thus providing a complete description of mutations underlying human oncogenesis. The recent identification of high frequency mutations in the BRAF and PI3K genes suggests that many more cancer genes remain to be discovered. In this review, we consider how the systematic mutational analysis of gene families in individual neoplasms has led to the identification of a number of cancer genes and how this information is influencing the treatment of cancer.

AB - It is now widely accepted that cancer is a genetic disease and that alterations in the DNA sequence underlie the development of every neoplasm. The identification of mutated genes that are causally implicated in oncogenesis ('cancer genes') has been a major goal in medical sciences for the last two decades. The availability of the human genome sequence coupled to the introduction of high throughput sequencing technologies has created an unprecedented opportunity in this field. It is now possible to perform mutational studies of entire cancer genomes thus providing a complete description of mutations underlying human oncogenesis. The recent identification of high frequency mutations in the BRAF and PI3K genes suggests that many more cancer genes remain to be discovered. In this review, we consider how the systematic mutational analysis of gene families in individual neoplasms has led to the identification of a number of cancer genes and how this information is influencing the treatment of cancer.

KW - Cancer genome

KW - Gene family

KW - Mutational analysis

KW - Oncogenomics

KW - Tailored therapies

UR - http://www.scopus.com/inward/record.url?scp=14844318078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844318078&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2005.02.015

DO - 10.1016/j.febslet.2005.02.015

M3 - Article

C2 - 15763568

AN - SCOPUS:14844318078

VL - 579

SP - 1884

EP - 1890

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 8

ER -